Stryker Corporation (SYK)
Stock Price:
$232.81 USD
-0.91 (-0.39%)
Updated November 27, 1:03 PM EST - Market closed
Key Info
| Market Cap |
87.49B |
| Revenue (ttm) |
14.22B |
| Net Income (ttm) |
1.76B |
| Shares Out |
375.79M |
| EPS (ttm) |
4.61 |
| PE Ratio |
50.50 |
| Forward PE |
25.91 |
| Dividend |
$2.30 |
| Dividend Yield |
0.99% |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$232.81 |
| Previous Close |
$233.72 |
| Change ($) |
-0.91 |
| Change (%) |
-0.39% |
| Day's Open |
236.17 |
| Day's Range |
231.81 - 236.60 |
| Day's Volume |
787,609 |
| 52-Week Range |
124.54 - 242.51 |
More Stats
| Market Cap |
87.49B |
| Enterprise Value |
93.45B |
| Earnings Date (est) |
Feb 2, 2021 |
| Ex-Dividend Date |
Sep 29, 2020 |
| Shares Outstanding |
375.79M |
| Float |
347.79M |
| EPS (basic) |
4.70 |
| EPS (diluted) |
4.61 |
| FCF / Share |
6.00 |
| Dividend |
$2.30 |
| Dividend Yield |
0.99% |
| Earnings Yield |
1.98% |
| FCF Yield |
2.58% |
| Payout Ratio |
48.90% |
| Shares Short |
3.15M |
| Short Ratio |
2.81 |
| Short % of Float |
0.91% |
| Beta |
0.84 |
| PE Ratio |
50.50 |
| Forward PE |
25.91 |
| P/FCF Ratio |
38.81 |
| PS Ratio |
6.15 |
| PB Ratio |
6.74 |
| Revenue |
14.22B |
| Operating Income |
2.42B |
| Net Income |
1.76B |
| Free Cash Flow |
2.25B |
| Net Cash |
-5.97B |
| Net Cash / Share |
-15.88 |
| Gross Margin |
68.92% |
| Operating Margin |
17.00% |
| Profit Margin |
12.30% |
| FCF Margin |
15.85% |
| ROA |
6.52% |
| ROE |
13.88% |
| ROIC |
11.30% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (28)
| Buy |
14 |
| Overweight |
2 |
| Hold |
11 |
| Underweight |
0 |
| Sell |
1 |
Analyst Consensus: Overweight
Price Target
$227.67*
(-2.21% downside)
Low
194
Current: $232.81
High
258
Target: 227.67
*Average 12-month price target from 24 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 14,884 | 13,601 | 12,444 | 11,325 | 9,946 | 9,675 | 9,021 | 8,657 | 8,307 | 7,320 |
| Revenue Growth | 9.43% | 9.3% | 9.88% | 13.86% | 2.8% | 7.25% | 4.2% | 4.21% | 13.48% | - |
| Gross Profit | 9,696 | 8,938 | 8,180 | 7,504 | 6,602 | 6,356 | 6,019 | 5,876 | 5,496 | 5,034 |
| Operating Income | 2,713 | 2,537 | 2,297 | 2,175 | 1,861 | 1,246 | 1,256 | 1,741 | 1,686 | 1,751 |
| Net Income | 2,083 | 3,553 | 1,020 | 1,647 | 1,439 | 515 | 1,006 | 1,298 | 1,345 | 1,273 |
| Shares Outstanding | 374 | 374 | 374 | 374 | 377 | 379 | 379 | 381 | 387 | 396 |
| Earnings Per Share | 5.48 | 9.34 | 2.68 | 4.35 | 3.78 | 1.34 | 2.63 | 3.39 | 3.45 | 3.19 |
| EPS Growth | -41.33% | 248.51% | -38.39% | 15.08% | 182.09% | -49.05% | -22.42% | -1.74% | 8.15% | - |
| Dividend Per Share | 2.14 | 1.93 | 1.75 | 1.57 | 1.42 | 1.26 | 1.10 | 0.90 | 0.75 | 0.63 |
| Dividend Growth | 10.62% | 10.6% | 11.5% | 10.6% | 12.3% | 14.55% | 21.82% | 20.08% | 19.37% | - |
| Operating Cash Flow | 2,191 | 2,610 | 1,559 | 1,915 | 981 | 1,782 | 1,886 | 1,657 | 1,434 | 1,547 |
| Capital Expenditures | -649 | -572 | -598 | -490 | -270 | -233 | -195 | -210 | -159 | -121 |
| Free Cash Flow | 1,542 | 2,038 | 961 | 1,425 | 711 | 1,549 | 1,691 | 1,447 | 1,275 | 1,426 |
| Cash & Equivalents | 4,425 | 3,699 | 2,793 | 3,384 | 4,079 | 5,000 | 3,980 | 4,285 | 3,418 | 4,380 |
| Total Debt | 11,090 | 9,859 | 7,222 | 6,914 | 3,998 | 3,973 | 2,764 | 1,762 | 1,768 | 1,021 |
| Net Cash / Debt | -6,665 | -6,160 | -4,429 | -3,530 | 81.00 | 1,027 | 1,216 | 2,523 | 1,650 | 3,359 |
| Assets | 30,167 | 27,229 | 22,197 | 20,435 | 16,223 | 17,279 | 15,743 | 13,206 | 12,146 | 10,895 |
| Liabilities | 17,360 | 15,499 | 12,217 | 10,885 | 7,712 | 8,684 | 6,696 | 4,609 | 4,463 | 3,721 |
| Book Value | 12,807 | 11,730 | 9,966 | 9,550 | 8,511 | 8,595 | 9,047 | 8,597 | 7,683 | 7,174 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Stryker Corporation |
| Country |
United States |
| Employees |
40,000 |
| CEO |
Kevin A. Lobo |
Stock Information
| Ticker Symbol |
SYK |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NYSE: SYK |
Description
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.